journal article·2018-07Open access

Targeted Chemo‐Photothermal Therapy: A Nanomedicine Approximation to Selective Melanoma Treatment

Gonzalo Villaverde, Sergio Gómez‐Graña, Eduardo Guisasola, Isabel García, Christoph Hanske, Luis M. Liz‐Marzán, Alejandro Baeza, Maria Vallet‐Regí

Abstract

Abstract Melanoma is one of the most severe public health issues worldwide, not only because of the high number of cases but also for its poor prognosis in late stages. Therefore, early diagnosis and efficient treatment are key toward a future solution. However, melanoma is highly resistant to cytotoxicity in its metastatic form. In this context, a therapeutic strategy based on a targeted chemo‐photothermal nanotransporter for cytotoxic compounds is proposed. This approach comprises the use of core–multishell gold nanorods, coated with mesoporous silica and further covered with a thermosensitive polymer, which is vectorized for selective internalization in melanoma cells. The proposed nanoformulation is capable of releasing the transported cytotoxic compounds on demand, in response to near‐IR irradiation, with high selectivity and efficacy against malignant cells, even at low concentrations, thereby providing a new tool against melanoma disease.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Dpto. de Química en Ciencias Farmacéuticas Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12.UCM. Centro de Investigación Biomédica en Red de Bioingeniería Biomateriales y Nanomedicina (CIBER‐BBN) Madrid 28040 Spain

CIC biomaGUNE and CIBER‐BBN Paseo de Miramón 182 20014 Donostia‐San/Sebastian Spain

Ikerbasque Basque Foundation for Science 48013 Bilbao Spain

Funding

European Research Council · Ministerio de Economía y Competitividad · Alexander von Humboldt-Stiftung

References (53)

Show source-provided references
1. 10.1111/pcmr.1247510.1111/pcmr.12475 ↗
2. 10.1038/nature0566110.1038/nature05661 ↗
3. 10.1053/j.semdp.2016.04.00710.1053/j.semdp.2016.04.007 ↗
4. Quinn T. · G. Ital. di dermatologia e Venereol. organo Uff. Soc. Ital. di dermatologia e Sifilogr. · 2010 · 145 · 245
5. 10.1021/bc100391a10.1021/bc100391a ↗
6. 10.3389/fendo.2017.0009310.3389/fendo.2017.00093 ↗
7. Cancer Research · 2002 · 62 · 3200
8. 10.1158/1541-7786.MCR-08-023510.1158/1541-7786.MCR-08-0235 ↗
9. 10.1038/sj.onc.120645410.1038/sj.onc.1206454 ↗
10. Lund V. J. · Rhinology. · 2010 · 22 · 1
11. 10.1038/s41598-016-0028-x10.1038/s41598-016-0028-x ↗
12. 10.1016/j.nano.2015.04.00110.1016/j.nano.2015.04.001 ↗
13. 10.1016/j.addr.2012.10.00210.1016/j.addr.2012.10.002 ↗
14. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
15. 10.1517/17425247.2014.95501110.1517/17425247.2014.955011 ↗
16. Mansour A. M. · Cancer Res. · 2003 · 63 · 4062
17. 10.1021/ja054700l10.1021/ja054700l ↗
18. 10.1039/c2jm32599c10.1039/c2jm32599c ↗
19. 10.1021/acsnano.7b0020310.1021/acsnano.7b00203 ↗
20. 10.1021/nn504764710.1021/nn5047647 ↗
21. 10.1021/nn901884d10.1021/nn901884d ↗
22. 10.1021/nl300389y10.1021/nl300389y ↗
23. 10.1038/8668410.1038/86684 ↗
24. 10.1021/nn304332s10.1021/nn304332s ↗
25. 10.1021/nl100996u10.1021/nl100996u ↗
26. 10.1021/nn900904h10.1021/nn900904h ↗
27. 10.1021/acsnano.5b0662310.1021/acsnano.5b06623 ↗
28. 10.1016/S1011-1344(00)00082-810.1016/S1011-1344(00)00082-8 ↗
29. 10.1146/annurev-pharmtox-010715-10345610.1146/annurev-pharmtox-010715-103456 ↗
30. 10.1007/s10103-007-0470-x10.1007/s10103-007-0470-x ↗
31. 10.1016/j.ccr.2005.01.03010.1016/j.ccr.2005.01.030 ↗
32. 10.1016/j.jconrel.2006.06.01710.1016/j.jconrel.2006.06.017 ↗
33. 10.1021/acsnano.5b0474410.1021/acsnano.5b04744 ↗
34. 10.1016/j.biomaterials.2013.01.05110.1016/j.biomaterials.2013.01.051 ↗
35. 10.1021/cm001155910.1021/cm0011559 ↗
36. 10.1002/anie.20060448810.1002/anie.200604488 ↗
37. 10.1021/cm203000u10.1021/cm203000u ↗
38. 10.1021/acs.langmuir.5b0347010.1021/acs.langmuir.5b03470 ↗
39. 10.1021/ja312221g10.1021/ja312221g ↗
40. 10.1007/s10853-018-2117-710.1007/s10853-018-2117-7 ↗
41. 10.1021/acsami.6b0096310.1021/acsami.6b00963 ↗
42. 10.1021/acs.langmuir.6b0367910.1021/acs.langmuir.6b03679 ↗
43. 10.1039/C4TB01631A10.1039/C4TB01631A ↗
44. 10.1007/s10853-017-0787-110.1007/s10853-017-0787-1 ↗
45. 10.1002/psc.66810.1002/psc.668 ↗
46. 10.1002/anie.19780522110.1002/anie.197805221 ↗
47. 10.3390/cancers603176910.3390/cancers6031769 ↗
48. 10.1016/j.biomaterials.2011.07.07110.1016/j.biomaterials.2011.07.071 ↗
49. 10.1186/s13058-015-0576-110.1186/s13058-015-0576-1 ↗
50. 10.1021/cm402177b10.1021/cm402177b ↗
51. 10.1021/acs.jpclett.5b0212310.1021/acs.jpclett.5b02123 ↗
52. 10.1002/adfm.20140072910.1002/adfm.201400729 ↗
53. Villaverde G. · Chem. ‐ Eur. J. · 2017 · 23 · 3010.1002/chem.201605947 ↗